Zobrazeno 1 - 3
of 3
pro vyhledávání: '"K. B. Klein"'
Publikováno v:
Neurology. 46(2)
311C90 is a novel, centrally and peripherally, acting 5-hydroxytryptamine1D receptor agonist. We investigated the efficacy and safety of 1, 5, and 25 mg of oral 311C90 in the acute treatment of migraine in a randomized, double-blind, placebo-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c71230094ad687cddfbd18e8f86f1a3
https://pubmed.ncbi.nlm.nih.gov/8614525
https://pubmed.ncbi.nlm.nih.gov/8614525
Publikováno v:
Lancet (London, England). 2(7871)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::349837166504a5dfdf9c2e84064212cb
https://pubmed.ncbi.nlm.nih.gov/4134438
https://pubmed.ncbi.nlm.nih.gov/4134438
Autor:
K. B. Klein, A. W. Pittman, J. W. A. Findlay, S. H. T. Liao, M. F. Frosolono, Ramadas Balasubramanian
Publikováno v:
Journal of clinical pharmacology. 29(5)
Six healthy male volunteers participated in this randomized, crossover open-label pharmacokinetic study consisting of two dosing segments separated by a washout period of at least 5 days. During each dosing segment, each volunteer received 12 mg of a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d10ce03051afe8a49f1046f5ab0b7d3
https://pubmed.ncbi.nlm.nih.gov/2567739
https://pubmed.ncbi.nlm.nih.gov/2567739